免疫缺陷与HIV病毒血症对南非HIV感染女性宫颈癌前病变及癌症风险的影响
结果显示较低CD4计数独立于HIV RNA与宫颈病变和癌症风险升高强相关,而HIV RNA的关联在调整CD4后减弱。维持高CD4计数和病毒抑制可能有助于改善宫颈癌预防。
要点
- 较低CD4计数独立于HIV RNA与宫颈癌前病变和癌症风险升高强相关。
- 30个月内最低CD4计数对宫颈病变最具信息量,滞后24个月CD4对宫颈癌最具信息量。
- HIV RNA与风险的关联在调整CD4计数后减弱。
核心结论
- 维持高CD4计数和实现病毒抑制,并结合CD4计数进行宫颈筛查风险分层,可能有助于改善南非HIV感染女性的宫颈癌预防。
研究设计与样本
- 采用Cox比例风险模型评估CD4细胞计数和HIV RNA与宫颈癌前病变及癌症的关联,并测试6-36个月滞后期的汇总和时点测量。
主要发现
- 1202名女性发生中度不典型增生(发病率394/10万人年),1237名发生重度不典型增生(405/10万人年),211名发生原位癌(66/10万人年),257名发生宫颈癌(70/10万人年)。
- 较低CD4计数与宫颈不典型增生、原位癌和癌症发病率升高强相关,且独立于HIV RNA。
- 30个月内最低CD4计数对宫颈不典型增生最具信息量,滞后24个月的CD4计数对宫颈癌最具信息量。
- 较高HIV RNA在未调整CD4计数的模型中与癌前病变和癌症风险升高相关,调整CD4后关联减弱。
临床怎么用
- 对HIV感染女性应尽早启动ART以维持高CD4计数和实现病毒抑制。
- 可考虑使用CD4细胞计数进行宫颈筛查风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Women with human immunodeficiency virus-1 (HIV) (WWH) have a higher cervical cancer risk than women without HIV. The timing and extent to which HIV viremia and immunodeficiency contribute to cervical carcinogenesis remain incompletely understood. METHODS: We conducted a cohort study using medical claims data from a South African HIV program (2011-2022) and calculated incidence rates of cervical precancer and cancer. Cox proportional hazards models assessed associations with CD4 cell count and HIV ribonucleic acid (RNA). We tested summary and point-in-time CD4 and HIV RNA measures with 6-36 months lag periods. Models were adjusted for age, calendar year, and antiretroviral therapy (ART) initiation; fully adjusted models included both CD4 count and HIV RNA. RESULTS: Over 66 000 WWH contributed more than 300 000 person-years; 1202 WWH developed moderate dysplasia (incidence rate: 394/100 000 person-years), 1237 severe dysplasia (405/100 000 person-years), 211 carcinoma in situ (66/100 000 person-years), and 257 cervical cancer (70/100 000 person-years). Lower CD4 counts were strongly associated with higher rates of cervical dysplasia, carcinoma in situ, and cancer, independent of HIV RNA. Lowest CD4 count over 30 months was the most informative measure for cervical dysplasia while CD4 count lagged by 24 months was most informative for cervical cancer. Higher HIV RNA was associated with increased risk of precancer and cancer in models unadjusted for CD4 count, with associations attenuated after adjustment. CONCLUSIONS: Maintaining high CD4 counts and achieving viral suppression through early ART initiation, along with using CD4 cell count for risk stratification in cervical screening, may help improve cervical cancer prevention among WWH in South Africa.
引用
- Ruffieux Y, Andoh J, Haas AD, et al. Association of Immunodeficiency and HIV Viremia With Cervical Precancer and Cancer Risk Among Women With HIV in South Africa. Clin Infect Dis. 2026. PMID: 41689274. doi:10.1093/cid/ciag093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。